Botfet / Company detail

HALO

universe

Halozyme Therapeutics, Inc.

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic23.2%

Gross Margin83.6%

Revenue Cagr33.2%

Fcf Conversion203.4%

Fcf Yield4.5%

Interest Coverage31.6x

Market Cap B$14.4B

Pe35.7

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener